loan agreement

The firm said it may use the loans to finance its $1.3 billion acquisition of Euroimmun Medical Laboratory Diagnostics.

Premaitha will issue Thermo Fisher warrants over 28,938,797 new ordinary shares and a second tranche of warrants in 2018. 

The loan from the European Investment Bank will go toward the development of Stat-Dx's diagnostic platform for detecting infectious pathogens, such as meningitis. 

The company said it ultimately plans to use the liquidity from the credit facility to fund a portion of its pending $4 billion acquisition of Cepheid.

The Belgian molecular diagnostics company said it will focus on expanding its capability to manufacture its Idylla diagnostics.

The Finnish firm is hoping to finalize manufacturing, validation, and commercialization of its new sample-to-result infectious disease diagnostics platform.

The company took out the credit in connection with its $4.2 billion pending acquisition of electron microscopy firm FEI.

The money is the second part of a loan agreement signed in 2014 with Oxford Finance and Silicon Valley Bank for a total of $16 million.

Thermo will invest £5 million in Premaitha as a secured loan facility, of which the firm will receive £3 million initially and the remainder as milestone payments.

Dragged down by sinking sales and test volumes at IDL, GeneNews looks to restructure its business.